JU
Jupiter Neurosciences, Inc.
JUNS · NASDAQ
$3.01 -12.75% (-$0.44)
1M -34.17%
Market Cap $1.65M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 25.55x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 54.62%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 15,166.70%
Gross margin 88.34%
FCF margin 11,206.00%
Quality
0 /100
Poor Asset turnover 0.02x
ROIC 709.40%
ROA 247.39%
Debt
7 /100
High Int. coverage -262.75x
Current ratio 0.66x
Debt/Assets N/A
Stability
4 /100
Unstable Profitable years 0
Beta 1.79x
EPS volatility 126.84%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o JUNS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christer Rosen
Employees
5
Headquarters
Jupiter
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report